NO20090252L - Camptotecinderivater med antitumoraktivitet - Google Patents

Camptotecinderivater med antitumoraktivitet

Info

Publication number
NO20090252L
NO20090252L NO20090252A NO20090252A NO20090252L NO 20090252 L NO20090252 L NO 20090252L NO 20090252 A NO20090252 A NO 20090252A NO 20090252 A NO20090252 A NO 20090252A NO 20090252 L NO20090252 L NO 20090252L
Authority
NO
Norway
Prior art keywords
tumor activity
derivatives
camptotecin
camptotecin derivatives
antitumor
Prior art date
Application number
NO20090252A
Other languages
English (en)
Other versions
NO342506B1 (no
Inventor
Gabriele Fontana
Ezio Bombardelli
Carla Manzotti
Arturo Battaglia
Cristian Samori
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20090252L publication Critical patent/NO20090252L/no
Publication of NO342506B1 publication Critical patent/NO342506B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nye camptotecinderivater som har antitumoraktivitet, prosessen for fremstilling derav, anvendelse derav som antitumorlegemidler og farmasøytiske sammensetninger inneholdende dem.
NO20090252A 2006-07-26 2009-01-16 Camptotecinderivater med antitumoraktivitet NO342506B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001474A ITMI20061474A1 (it) 2006-07-26 2006-07-26 Derivati della camptotecina ad attivita antitumorale
PCT/EP2007/006294 WO2008012003A1 (en) 2006-07-26 2007-07-16 Camptothecin derivatives with antitumor activity

Publications (2)

Publication Number Publication Date
NO20090252L true NO20090252L (no) 2009-01-16
NO342506B1 NO342506B1 (no) 2018-06-04

Family

ID=38668855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090252A NO342506B1 (no) 2006-07-26 2009-01-16 Camptotecinderivater med antitumoraktivitet

Country Status (19)

Country Link
US (1) US8193210B2 (no)
EP (1) EP2044080B1 (no)
JP (1) JP5313895B2 (no)
KR (1) KR101496374B1 (no)
CN (1) CN101495485B (no)
AU (1) AU2007278509B2 (no)
BR (1) BRPI0714672B8 (no)
CA (1) CA2658902C (no)
DK (1) DK2044080T3 (no)
ES (1) ES2628022T3 (no)
IL (1) IL196652A0 (no)
IT (1) ITMI20061474A1 (no)
MX (1) MX2009000828A (no)
NO (1) NO342506B1 (no)
PL (1) PL2044080T3 (no)
PT (1) PT2044080T (no)
RU (1) RU2450007C2 (no)
SI (1) SI2044080T1 (no)
WO (1) WO2008012003A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9379559B2 (en) 2012-02-03 2016-06-28 International Business Machines Corporation System and method of charging a vehicle using a dynamic power grid, and system and method of managing power consumption in the vehicle
PL235836B1 (pl) * 2012-10-25 2020-11-02 Inst Chemii Organicznej Polskiej Akademii Nauk Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
CN108690036B (zh) * 2018-05-22 2021-05-25 北京海步医药科技股份有限公司 一种10-二氟甲基喜树碱类化合物及其制备方法和应用
LU102067B1 (en) 2020-09-17 2022-03-18 Narodowy Inst Lekow 7-Ethyl-10-hydroxycamptothecin derivatives for use in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972955A (en) 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali

Also Published As

Publication number Publication date
HK1135692A1 (en) 2010-06-11
NO342506B1 (no) 2018-06-04
RU2450007C2 (ru) 2012-05-10
AU2007278509A1 (en) 2008-01-31
KR20090032100A (ko) 2009-03-31
EP2044080A1 (en) 2009-04-08
IL196652A0 (en) 2009-11-18
ITMI20061474A1 (it) 2008-01-27
SI2044080T1 (sl) 2017-07-31
EP2044080B1 (en) 2017-05-10
CN101495485A (zh) 2009-07-29
ES2628022T3 (es) 2017-08-01
JP5313895B2 (ja) 2013-10-09
BRPI0714672A2 (pt) 2013-03-26
CA2658902C (en) 2014-09-23
CA2658902A1 (en) 2008-01-31
CN101495485B (zh) 2012-04-11
MX2009000828A (es) 2009-02-03
DK2044080T3 (en) 2017-07-17
AU2007278509B2 (en) 2012-10-04
BRPI0714672B1 (pt) 2020-10-20
RU2009102241A (ru) 2010-07-27
WO2008012003A1 (en) 2008-01-31
PL2044080T3 (pl) 2017-10-31
PT2044080T (pt) 2017-06-15
US20100010032A1 (en) 2010-01-14
KR101496374B1 (ko) 2015-03-04
JP2010500971A (ja) 2010-01-14
BRPI0714672B8 (pt) 2021-05-25
US8193210B2 (en) 2012-06-05

Similar Documents

Publication Publication Date Title
NO20090251L (no) Camptotecinderivater med antitumoraktivitet
UA107474C2 (uk) Похідні хроменону з антипухлинною активністю
UA107951C2 (xx) Похідні імідазопіридину як інгібітори jak
NO20071504L (no) Pyrimidinderivanter.
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
DOP2010000013A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20090295L (no) Substituerte heteroarylderivater
DOP2010000259A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UA110199C2 (xx) Тверда дисперсія рифаксиміну
TW200611904A (en) Aza-bicyclononanes
MX2010002210A (es) Derivados de catecolamina y profarmacos de los mismos.
CR20110210A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
NO20084352L (no) Dimerer av artemisininderivater, fremstilling derav og terapeutisk anvendelse derav
MY173564A (en) Cxcr7 receptor modulators
EA201400444A1 (ru) Производные 2-оксопиперидинила
NO20090252L (no) Camptotecinderivater med antitumoraktivitet
ATE556062T1 (de) 3,4-dihydrochinazolinderivate
CY1110787T1 (el) Νεα μορφινικα παραγωγα
PH12015500282A1 (en) N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug
DK2044078T3 (da) Camptothecinderivater med antitumoraktivitet
JO2861B1 (en) (Use of 4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF CRANIAL TRAUMAS)
GB0620619D0 (en) Novel compounds
CU20100005A7 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees